Siga Technologies Inc financial data

Symbol
SIGA on Nasdaq
Industry
Pharmaceutical Preparations
Location
31 East 62 Nd Street, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
SIGA PHARMACEUTICALS INC (to 5/25/2000)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 436 % -45.3%
Quick Ratio 137 % -27.5%
Debt-to-equity 29.8 % +87.4%
Return On Equity 51.4 % +184%
Return On Assets 39.6 % +154%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.4M shares +0.4%
Common Stock, Shares, Outstanding 71.3M shares +0.31%
Entity Public Float 231M USD -58%
Common Stock, Value, Issued 7.13K USD +0.31%
Weighted Average Number of Shares Outstanding, Basic 71.2M shares +0.09%
Weighted Average Number of Shares Outstanding, Diluted 71.8M shares +0.93%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 173M USD +76.9%
Research and Development Expense 12.2M USD -45.3%
Costs and Expenses 70.2M USD +10.7%
Operating Income (Loss) 103M USD +199%
Nonoperating Income (Expense) 8.34M USD +150%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 108M USD +189%
Income Tax Expense (Benefit) 24.1M USD +170%
Net Income (Loss) Attributable to Parent 84M USD +195%
Earnings Per Share, Basic 1.17 USD/shares +208%
Earnings Per Share, Diluted 1.17 USD/shares +200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 107M USD +40.3%
Accounts Receivable, after Allowance for Credit Loss, Current 8.95M USD +48.6%
Inventory, Net 55.7M USD +10.2%
Assets, Current 176M USD +31.4%
Deferred Income Tax Assets, Net 11.6M USD +53%
Property, Plant and Equipment, Net 1.52M USD -5.48%
Goodwill 898K USD 0%
Other Assets, Noncurrent 2.16M USD +1.82%
Assets 193M USD +31.5%
Accounts Payable, Current 1.03M USD -4.46%
Accrued Liabilities, Current 6.53M USD -63.5%
Contract with Customer, Liability, Current 13.7M USD +20.7%
Liabilities, Current 21.4M USD +12.6%
Operating Lease, Liability, Noncurrent 1.1M USD
Liabilities 25.1M USD +11.9%
Retained Earnings (Accumulated Deficit) -70M USD +36.9%
Stockholders' Equity Attributable to Parent 168M USD +35%
Liabilities and Equity 193M USD +31.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.12M USD -125%
Net Cash Provided by (Used in) Financing Activities -159K USD +97.9%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 71.3M shares +0.31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 107M USD +40.3%
Deferred Tax Assets, Valuation Allowance 944K USD -4.25%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 12.5M USD +60.5%
Operating Lease, Liability 1.65M USD -7.84%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -6.3%
Property, Plant and Equipment, Gross 7.38M USD +6.69%
Operating Lease, Liability, Current 524K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 686K USD +68.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 683K USD +0.68%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +110%
Deferred Income Tax Expense (Benefit) 36.5K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 171K USD +11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 166K USD -59.5%
Deferred Tax Assets, Operating Loss Carryforwards 1.19M USD -4.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 5.08M USD -0.43%
Lessee, Operating Lease, Liability, to be Paid, Year Four 410K USD 0%
Operating Lease, Payments 700K USD +16.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 138K USD +5.61%
Deferred Tax Assets, Net of Valuation Allowance 11.5M USD +69.9%